newsfilter
← Latest News
GlobeNewswire·

Amryt Announces Details of EMA Contingent Value Rights Payment

Amryt Announces Details of EMA Contingent Value Rights Payment DUBLIN, Ireland, and Boston MA, May 17, 2022 Amryt (NASDAQ:AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatme